FDA Approves Humira Biosimilar Hadlima for Treatment of Ankylosing Spondylitis - Ankylosing Spondylitis News

FDA Approves Humira Biosimilar Hadlima for Treatment of Ankylosing Spondylitis  Ankylosing Spondylitis News

Hadlima (adalimumab-bwwd), a biosimilar to Humira, has been approved by the FDA for the treatment of ankylosing spondylitis.